Difference between revisions of "Team:Grenoble-Alpes/actors partnerships"

Line 63: Line 63:
 
<div id="text-container">
 
<div id="text-container">
  
 +
<p>We discussed with a lot of people to develop our project, to better understand what is useful to implement, create and integrate into our project from their remarks. </p>
  
 +
 +
    <p>  <b>GROUND FLOOR: </b>  We established partnerships with local companies like Biomérieux and local laboratories like TIMC in order to benefit from their advice/expertise and we had the opportunity to get some of their biological material. Our engineers and researcher partners gave us a lot of recommendations all along the summer and helped us to get an external point of view on our project.</p>
 +
 +
    <p><b>  FIRST FLOOR:</b>  We visited a medical analysis laboratory and we met the laboratory manager. We discussed with him about the detection system used in his laboratory and about the advantages and limits of our system, if it was used in this kind of laboratory. </p>
 +
 +
  <p> <b>SECOND FLOOR:</b> We met with doctors and patients who talked with us about bacteriophages and antibiotic resistance. We discussed with them to know if our detection system could be used in hospitals and what modification we should make in order to improve it. You can have a look at them on the third floor (see our schematic below). </p>
 +
 +
  <p><b>    THIRD FLOOR:</b> All the societies must be implicated in our project. But it’s /essential for us to be aware of what people know about phage therapy and antimicrobial resistance. It’s important to evaluate people's knowledge and then produce an appropriate outreach. </p>
 +
 +
 +
<br>
 +
<figure><center><img src="https://static.igem.org/mediawiki/2018/8/8d/T--Grenoble-Alpes--actors%26partbuilding.png" style="width:70vh"></center></figure>
 +
<br>
  
  

Revision as of 09:53, 14 October 2018

Template loop detected: Template:Grenoble-Alpes

ACTORS AND PARTNERSHIPS

We discussed with a lot of people to develop our project, to better understand what is useful to implement, create and integrate into our project from their remarks.

GROUND FLOOR: We established partnerships with local companies like Biomérieux and local laboratories like TIMC in order to benefit from their advice/expertise and we had the opportunity to get some of their biological material. Our engineers and researcher partners gave us a lot of recommendations all along the summer and helped us to get an external point of view on our project.

FIRST FLOOR: We visited a medical analysis laboratory and we met the laboratory manager. We discussed with him about the detection system used in his laboratory and about the advantages and limits of our system, if it was used in this kind of laboratory.

SECOND FLOOR: We met with doctors and patients who talked with us about bacteriophages and antibiotic resistance. We discussed with them to know if our detection system could be used in hospitals and what modification we should make in order to improve it. You can have a look at them on the third floor (see our schematic below).

THIRD FLOOR: All the societies must be implicated in our project. But it’s /essential for us to be aware of what people know about phage therapy and antimicrobial resistance. It’s important to evaluate people's knowledge and then produce an appropriate outreach.